Cardlytics (NASDAQ:CDLX) Lowered to Hold at Northland Capmk

Northland Capmk lowered shares of Cardlytics (NASDAQ:CDLX - Free Report) from a strong-buy rating to a hold rating in a research report sent to investors on Friday, Zacks.com reports.

Other research analysts have also issued reports about the company. Needham & Company LLC lowered Cardlytics from a buy rating to a hold rating in a research report on Thursday, August 8th. Northland Securities lowered Cardlytics from an outperform rating to a market perform rating and dropped their price target for the company from $7.00 to $5.00 in a research report on Friday. Bank of America lowered Cardlytics from a neutral rating to an underperform rating and dropped their price target for the company from $4.00 to $3.50 in a research report on Thursday. Lake Street Capital downgraded Cardlytics from a buy rating to a hold rating and lowered their target price for the company from $18.00 to $5.00 in a research note on Thursday, August 8th. Finally, Craig Hallum downgraded Cardlytics from a buy rating to a hold rating in a research note on Thursday, August 8th. One investment analyst has rated the stock with a sell rating and five have issued a hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of Hold and a consensus target price of $7.50.

Cardlytics Trading Down 1.9 %

Shares of Cardlytics stock traded down $0.07 on Friday, reaching $3.68. 1,520,173 shares of the company were exchanged, compared to its average volume of 1,394,043. The stock has a fifty day moving average price of $7.61 and a 200-day moving average price of $9.44. The firm has a market capitalization of $179.52 million, a price-to-earnings ratio of -0.83 and a beta of 1.65. The company has a current ratio of 2.13, a quick ratio of 2.13 and a debt-to-equity ratio of 1.30. Cardlytics has a fifty-two week low of $2.89 and a fifty-two week high of $20.52.

Cardlytics (NASDAQ:CDLX - Get Free Report) last announced its earnings results on Wednesday, August 7th. The company reported ($0.09) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.21) by $0.12. The company had revenue of $69.64 million for the quarter, compared to analyst estimates of $75.39 million. Cardlytics had a negative return on equity of 25.36% and a negative net margin of 55.23%. Cardlytics's revenue for the quarter was down 9.2% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.57) earnings per share. On average, analysts expect that Cardlytics will post -1.8 EPS for the current year.

Insider Buying and Selling

In related news, insider Nicholas Hollmeyer Lynton sold 5,956 shares of the business's stock in a transaction dated Tuesday, July 2nd. The stock was sold at an average price of $7.95, for a total transaction of $47,350.20. Following the completion of the transaction, the insider now owns 78,593 shares of the company's stock, valued at approximately $624,814.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Cardlytics news, insider Nicholas Hollmeyer Lynton sold 5,956 shares of the company's stock in a transaction that occurred on Tuesday, July 2nd. The stock was sold at an average price of $7.95, for a total value of $47,350.20. Following the completion of the transaction, the insider now owns 78,593 shares of the company's stock, valued at approximately $624,814.35. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Alexis Desieno sold 7,451 shares of the company's stock in a transaction that occurred on Tuesday, July 2nd. The shares were sold at an average price of $7.95, for a total value of $59,235.45. Following the completion of the transaction, the chief financial officer now directly owns 6,898 shares of the company's stock, valued at approximately $54,839.10. The disclosure for this sale can be found here. In the last 90 days, insiders sold 86,742 shares of company stock valued at $735,905. Insiders own 4.40% of the company's stock.

Hedge Funds Weigh In On Cardlytics

A number of hedge funds have recently modified their holdings of the stock. Price T Rowe Associates Inc. MD raised its holdings in shares of Cardlytics by 6.3% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 29,769 shares of the company's stock worth $432,000 after buying an additional 1,774 shares in the last quarter. Canton Hathaway LLC boosted its position in Cardlytics by 95.7% in the 2nd quarter. Canton Hathaway LLC now owns 4,500 shares of the company's stock valued at $37,000 after buying an additional 2,200 shares during the last quarter. Brown Advisory Inc. boosted its position in Cardlytics by 1.7% in the 4th quarter. Brown Advisory Inc. now owns 199,633 shares of the company's stock valued at $1,839,000 after buying an additional 3,257 shares during the last quarter. Susquehanna Fundamental Investments LLC boosted its position in Cardlytics by 13.8% in the 1st quarter. Susquehanna Fundamental Investments LLC now owns 31,536 shares of the company's stock valued at $457,000 after buying an additional 3,836 shares during the last quarter. Finally, Shikiar Asset Management Inc. boosted its position in Cardlytics by 36.2% in the 1st quarter. Shikiar Asset Management Inc. now owns 40,175 shares of the company's stock valued at $582,000 after buying an additional 10,675 shares during the last quarter. 68.10% of the stock is owned by institutional investors and hedge funds.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.